{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:50:33Z","timestamp":1781974233759,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-026-00794-5","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:43:38Z","timestamp":1777952618000},"page":"473-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Non-statin Lipid-Lowering Therapies Implementation and Statin Treatment Intensification on Lipid Status in Heart Transplant Recipients: A Single-Centre Retrospective Cohort Study"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-814X","authenticated-orcid":false,"given":"Daniela","family":"Bacich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Giuseppe","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Faggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pradegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tessari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Tarzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"2","key":"794_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jacl.2019.01.011","volume":"13","author":"BA Warden","year":"2019","unstructured":"Warden BA, Duell PB. Management of dyslipidemia in adult solid organ transplant recipients. J Clin Lipidol. 2019;13(2):231\u201345. https:\/\/doi.org\/10.1016\/j.jacl.2019.01.011.","journal-title":"J Clin Lipidol"},{"issue":"3","key":"794_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13794","volume":"34","author":"F Lee","year":"2020","unstructured":"Lee F, Nair V, Chih S. Cardiac allograft vasculopathy: insights on pathogenesis and therapy. Clin Transplant. 2020;34(3):e13794. https:\/\/doi.org\/10.1111\/ctr.13794.","journal-title":"Clin Transplant"},{"issue":"10","key":"794_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM199509073331003","volume":"333","author":"JA Kobashigawa","year":"1995","unstructured":"Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333(10):621\u20137. https:\/\/doi.org\/10.1056\/NEJM199509073331003.","journal-title":"N Engl J Med"},{"issue":"1","key":"794_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0002-9149(03)00456-9","volume":"92","author":"VY See Jr","year":"2003","unstructured":"See VY Jr, DeNofrio D, Goldberg L, Chang G, Sasseen B, Kolansky DM, et al. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction. Am J Cardiol. 2003;92(1):11\u20135. https:\/\/doi.org\/10.1016\/s0002-9149(03)00456-9.","journal-title":"Am J Cardiol"},{"issue":"5","key":"794_CR5","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/01.cir.96.5.1398","volume":"96","author":"K Wenke","year":"1997","unstructured":"Wenke K, Meiser B, Thiery J, Nagel D, von Scheidt W, Steinbeck G, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation. 1997;96(5):1398\u2013402. https:\/\/doi.org\/10.1161\/01.cir.96.5.1398.","journal-title":"Circulation"},{"issue":"3","key":"794_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.amjcard.2004.09.035","volume":"95","author":"AH Wu","year":"2005","unstructured":"Wu AH, Ballantyne CM, Short BC, Torre-Amione G, Young JB, Ventura HO, et al. Statin use and risks of death or fatal rejection in the heart transplant lipid registry. Am J Cardiol. 2005;95(3):367\u201372. https:\/\/doi.org\/10.1016\/j.amjcard.2004.09.035.","journal-title":"Am J Cardiol"},{"issue":"5","key":"794_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","volume":"42","author":"A Velleca","year":"2023","unstructured":"Velleca A, Shullo MA, Dhital K, Azeka E, Colvin M, DePasquale E, et al. The international society for heart and lung transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2023;42(5):e1\u2013141. https:\/\/doi.org\/10.1016\/j.healun.2022.10.015.","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"794_CR8","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1177\/1060028013504077","volume":"47","author":"KM Makkar","year":"2013","unstructured":"Makkar KM, Sanoski CA, Goldberg LR, Spinler SA. An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors. Ann Pharmacother. 2013;47(11):1457\u201362. https:\/\/doi.org\/10.1177\/1060028013504077.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"794_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.healun.2008.02.014","volume":"27","author":"CC Quarta","year":"2008","unstructured":"Quarta CC, Potena L, Grigioni F, Scalone A, Magnani G, Coccolo F, et al. Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. J Heart Lung Transplant. 2008;27(6):685\u20138. https:\/\/doi.org\/10.1016\/j.healun.2008.02.014.","journal-title":"J Heart Lung Transplant"},{"issue":"15","key":"794_CR10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","volume":"388","author":"SE Nissen","year":"2023","unstructured":"Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, et al. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients. N Engl J Med. 2023;388(15):1353\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2215024.","journal-title":"N Engl J Med"},{"issue":"12","key":"794_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006910","volume":"6","author":"A Karatasakis","year":"2017","unstructured":"Karatasakis A, Danek BA, Karacsonyi J, Rangan BV, Roesle MK, Knickelbine T, et al. Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials. J Am Heart Assoc. 2017;6(12):e006910. https:\/\/doi.org\/10.1161\/JAHA.117.006910.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"794_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10741-022-10255-5","volume":"28","author":"DL Jennings","year":"2023","unstructured":"Jennings DL, Sultan L, Mingov J, Choe J, Latif F, Restaino S, et al. PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis. Heart Fail Rev. 2023;28(1):149\u201356. https:\/\/doi.org\/10.1007\/s10741-022-10255-5.","journal-title":"Heart Fail Rev"},{"issue":"12","key":"794_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/cvr\/cvae109","volume":"120","author":"RS Wright","year":"2024","unstructured":"Wright RS, Raal FJ, Koenig W, Landmesser U, Leiter LA, Vikarunnessa S, et al. Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial. Cardiovasc Res. 2024;120(12):1400\u201310. https:\/\/doi.org\/10.1093\/cvr\/cvae109.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"794_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.18087\/cardio.2024.7.n2679","volume":"64","author":"ZG Tatarintseva","year":"2024","unstructured":"Tatarintseva ZG, Tkhatl LK, Barbuhatti KO, Kosmacheva ED. [A case of successful treatment of severe hyperlipidemia after heart transplantation with inclisiran]. Kardiologiia. 2024;64(7):72\u20136. https:\/\/doi.org\/10.18087\/cardio.2024.7.n2679.","journal-title":"Kardiologiia"},{"key":"794_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11104","volume":"36","author":"L Ueberdiek","year":"2023","unstructured":"Ueberdiek L, Jehn U, Pavenst\u00e4dt H, Gebauer K, Reuter S. Novel therapeutic strategies for dyslipidemia: first report of Inclisiran therapy in a kidney transplanted patient. Transpl Int. 2023;36:11104. https:\/\/doi.org\/10.3389\/ti.2023.11104.","journal-title":"Transpl Int"},{"issue":"5","key":"794_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jalm\/jfad047","volume":"8","author":"S Lu","year":"2023","unstructured":"Lu S, Robyak K, Zhu Y. The CKD-EPI 2021 equation and other creatinine-based race-independent eGFR equations in chronic kidney disease diagnosis and staging. J Appl Lab Med. 2023;8(5):952\u201361. https:\/\/doi.org\/10.1093\/jalm\/jfad047.","journal-title":"J Appl Lab Med"},{"issue":"6","key":"794_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"issue":"10","key":"794_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","volume":"40","author":"KK Khush","year":"2021","unstructured":"Khush KK, Hsich E, Potena L, Cherikh WS, Chambers DC, Harhay MO, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40(10):1035\u201349. https:\/\/doi.org\/10.1016\/j.healun.2021.07.015.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"794_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"issue":"8","key":"794_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","volume":"29","author":"MR Costanzo","year":"2010","unstructured":"Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914\u201356. https:\/\/doi.org\/10.1016\/j.healun.2010.05.034.","journal-title":"J Heart Lung Transplant"},{"issue":"39","key":"794_CR21","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999\u20133058. https:\/\/doi.org\/10.1093\/eurheartj\/ehw272.","journal-title":"Eur Heart J"},{"issue":"4","key":"794_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.healun.2007.01.020","volume":"26","author":"O Biadi","year":"2007","unstructured":"Biadi O, Potena L, Fearon WF, Luikart HI, Yeung A, Ferrara R, et al. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant. 2007;26(4):324\u201330. https:\/\/doi.org\/10.1016\/j.healun.2007.01.020.","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"794_CR23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s10157-019-01776-9","volume":"23","author":"JE Kim","year":"2019","unstructured":"Kim JE, Yu MY, Kim YC, Min SI, Ha J, Lee JP, et al. Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients. Clin Exp Nephrol. 2019;23(12):1407\u201317. https:\/\/doi.org\/10.1007\/s10157-019-01776-9.","journal-title":"Clin Exp Nephrol"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-026-00794-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00794-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:10:58Z","timestamp":1781971858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-026-00794-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s40292-026-00794-5","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During preparation of this work authors HAVE NOT USED generative AI.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}}]}}